Tricuspid Regurgitation clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for

  • A Study to Evaluate an Experimental Tricuspid Valve Repair System (TRILUMINATE Study)

    open to eligible people ages 18 years and up

    The primary objective of this trial is to demonstrate the safety and effectiveness of the TriClip device in improving clinical outcomes in symptomatic patients with severe tricuspid regurgitation (TR), who are at intermediate or greater estimated risk for mortality or morbidity with tricuspid valve surgery. This randomized controlled trial will compare the investigational device (TriClip device) to Control (Medical Therapy).

    at UC Davis

  • Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

    open to eligible people ages 18 years and up

    To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

    at UCLA

Our lead scientists for Tricuspid Regurgitation research studies include .

Last updated: